Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel Prestigiacomo
Observed name:
Rachel D. Prestigiacomo
Institutions:
Tufts University,
University of Massachusetts Chan Medical School
Observed institutions:
Tufts University,
University of Massachusetts Chan Medical School
ORCID:
0009-0007-0519-427X
Observed ORCID:
0009-0007-0519-427X
OpenAlex ID:
A5055309378
BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease
2025
·
Jiaming Wang
, Laura E. Poskitt
, et al.
·
Science Translational Medicine
·
14
Awake intracerebroventricular delivery and safety assessment of oligonucleotides in a large animal model
2023
·
Hector Ribeiro Benatti
, Rachel D. Prestigiacomo
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
4
Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep
2025
·
Toloo Taghian
, Jillian Gallagher
, et al.
·
Journal of Clinical Investigation
·
3
From mouse to sheep: Generating a sheep model and developing a gene therapy for sialidosis
2023
·
Jillian Gallagher
, Judith Gallant
, et al.
·
Molecular Genetics and Metabolism
·
1
Cerebrospinal delivery of a bidirectional AAV9 vector improves optic nerve and retinal pathology in a sheep model of Tay-Sachs disease
2026
·
Brett D. Story
, Sara M. Thomasy
, et al.
·
Molecular Therapy
Testing a dual AAV gene therapy vector construct to treat sialidosis and galactosialidosis using small and large animal models
2026
·
Jillian Gallagher
, Stephanie Brownell
, et al.
·
Molecular Genetics and Metabolism
Adeno-associated viral gene therapy for sialidosis using small and large animal models
2024
·
Jillian Gallagher
, Judith Gallant
, et al.
·
Molecular Genetics and Metabolism
Show more works
View as search
Works count:
7
Citation count:
22
H-index:
3
I10-index:
1
Year
Topic
Type